quant Healthcare Fund - Growth Option - Regular Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 17.6062 ↑ 0.42%
[as on 2 November, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 40 SMA
  • 500 SMA

Returns

CAGR returns till date

CAGR returns of quant Healthcare Fund - Growth Option - Regular Plan and its peers as on 2 November, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
quant Healthcare Fund - Growth Option - Regular Plan 17.68% 0.42% 4.17% -0.74% 0.94% 14.62% 19.17%---
SBI MNC FUND - REGULAR PLAN -GROWTH 10.97% 0.76% 2.91% -1.37% -4.37% 9.5% 6.24% 6.5% 11.65% 10.32%
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 21.07% 0.61% 3.01% 1.04% -0.98% 16.5% 23.22% 17.89% 23.4% 13.78%
SBI COMMA Fund - REGULAR PLAN - Growth 0.8% 0.52% 2.72% -0.7% -4.78% 1.88% 14.13% 9.06% 16.65% 13.73%
SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth -5.29% 1.31% 3.83% 3.85% -5.01% -4.45% 8.98% 6.45% 11.2% 11.03%
SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH -1.4% 0.59% 3.73% 2.11% -5.38% -2.2% 11.18% 14.06% 17.54% 14.3%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 30.19% -6.4%

Discrete returns (monthly)

MonthJan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026Oct 2026
Returns -5.2% 2.44% -5.47% 6.1% 4.92% 6.43% 2.69% 5.79% -2.96% -0.74%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 2.12%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
70.33% 5.57% (Arbitrage: 0.00%) 0.00% 0.00% -4.55%

Equity

NameSymbol / ISINSectorWeight %Other links
Glaxosmithkline Pharmaceuticals LtdGLAXO (INE159A01016)Pharmaceuticals & Biotechnology10.58%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology9.30%
Pfizer LtdPFIZER (INE182A01018)Pharmaceuticals & Biotechnology8.83%
Alivus Life SciencesALIVUS (INE03Q201024)Pharmaceuticals & Biotechnology8.08%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology7.03%
SMS Pharmaceuticals LimitedSMSPHARMA (INE812G01025)Pharmaceuticals & Biotechnology6.71%
IPCA Laboratories LtdIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology6.22%
Zydus Wellness LtdZYDUSWELL (INE768C01028)Food Products5.64%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology5.18%
Strides Pharma Science LtdSTAR (INE939A01011)Pharmaceuticals & Biotechnology2.45%
Sumitomo Chemical India LimitedSUMICHEM (INE258G01013)Fertilizers & Agrochemicals0.31%

Debt

NameIsinRatingWeight %Yield
91 Days Treasury Bill 03-Sep-2026IN002026X099N.A.0.70%5.20%
91 Days Treasury Bill 10-Sep-2026IN002026X107N.A.0.70%5.18%
91 Days Treasury Bill 17-Sep-2026IN002026X115N.A.0.70%5.00%
91 Days Treasury Bill 15-Oct-2026IN002026X156N.A.0.70%5.11%
91 Days Treasury Bill 22-Oct-2026IN002026X164N.A.0.70%5.10%
91 Days Treasury Bill 05-Nov-2026IN002026X180N.A.0.69%5.25%
91 Days Treasury Bill 19-Nov-2026IN002026X206N.A.0.69%5.26%
91 Days Treasury Bill 27-Nov-2026IN002026X214N.A.0.69%5.27%
Portfolio data is as on date 31 August, 2026

NAV history

quant Healthcare Fund - Growth Option - Regular Plan - 30 days NAV (Net asset value) history

DateNAV% change
2 November, 202617.6062 0.42%
30 October, 202617.532 0.12%
29 October, 202617.5113 0.81%
28 October, 202617.3711 0.54%
27 October, 202617.2775 2.23%
26 October, 202616.9006 1.81%
23 October, 202616.5996 -1.45%
22 October, 202616.8433 -0.25%
21 October, 202616.8859 -0.72%
19 October, 202617.009 -1.21%
16 October, 202617.2168 -0.64%
15 October, 202617.3281 -0.41%
14 October, 202617.3999 -0.91%
13 October, 202617.5598 0.37%
12 October, 202617.4954 0.34%
9 October, 202617.4363 0.91%
8 October, 202617.2791 -2.34%
7 October, 202617.6925 -0.82%
6 October, 202617.8394 1.11%
5 October, 202617.6436 -0.53%
1 October, 202617.7372 -0.9%
30 September, 202617.8982 -1.61%
29 September, 202618.192 -0.14%
28 September, 202618.2166 -0.6%
25 September, 202618.3263 -0.39%
24 September, 202618.3974 -0.58%
23 September, 202618.505 0.83%
22 September, 202618.3532 -0.62%
21 September, 202618.468 0.53%
18 September, 202618.3701

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of quant Healthcare Fund - Growth Option - Regular Plan?
    The latest NAV of quant Healthcare Fund - Growth Option - Regular Plan is 17.6062 as on 2 November, 2026.
  • What are YTD (year to date) returns of quant Healthcare Fund - Growth Option - Regular Plan?
    The YTD (year to date) returns of quant Healthcare Fund - Growth Option - Regular Plan are 17.68% as on 2 November, 2026.
  • What are 1 year returns of quant Healthcare Fund - Growth Option - Regular Plan?
    The 1 year returns of quant Healthcare Fund - Growth Option - Regular Plan are 14.62% as on 2 November, 2026.
  • What are 3 year CAGR returns of quant Healthcare Fund - Growth Option - Regular Plan?
    The 3 year annualized returns (CAGR) of quant Healthcare Fund - Growth Option - Regular Plan are 19.17% as on 2 November, 2026.
  • What are top 10 holdings of quant Healthcare Fund - Growth Option - Regular Plan?
    Top 10 holdings of quant Healthcare Fund - Growth Option - Regular Plan are:
    • Glaxosmithkline Pharmaceuticals Ltd
    • Zydus Lifesciences Limited
    • Pfizer Ltd
    • Alivus Life Sciences
    • Concord Biotech Limited
    • SMS Pharmaceuticals Limited
    • IPCA Laboratories Ltd
    • Zydus Wellness Ltd
    • Aurobindo Pharma Limited
    • Strides Pharma Science Ltd
    • Sumitomo Chemical India Limited
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for quant Healthcare Fund - Growth Option - Regular Plan?
    quant Healthcare Fund - Growth Option - Regular Plan is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.